CHINA ORAL IND(08406)

Search documents
中国口腔产业(08406) - 2024 - 年度财报
2025-04-30 11:00
Financial Performance - In 2024, the company achieved total revenue of 231 million yuan, a significant year-on-year increase of 38.37%[11] - The net loss for the year was 16.439 million yuan, representing a year-on-year decrease of 11.74%[11] - The gross profit margin was maintained at 16.1%, and the debt-to-asset ratio stood at 47.08%, indicating a stable financial structure[11] - The gross profit for 2024 was approximately RMB 37,251,000, reflecting a 37.8% increase from RMB 27,035,000 in 2023[25] - The company anticipates a favorable outlook for 2025, driven by a gradual recovery in the global economy[21] - The annual loss for 2024 is approximately RMB 16,439,000, a reduction of about RMB 2,187,000 or 11.7% from 2023 (RMB 18,626,000) [31] - The total equity attributable to the owners of the company as of December 31, 2024, is approximately RMB 107,138,000, compared to RMB 104,665,000 in 2023 [34] - The financing cost for 2024 is approximately RMB 753,000, a decrease of about RMB 262,000 or 25.8% compared to 2023 (RMB 1,015,000) [30] Revenue Breakdown - In 2024, the company's revenue increased by approximately RMB 64,042,000 or 38.4% to about RMB 230,959,000 compared to RMB 166,917,000 in 2023[23] - The inflatable products business generated revenue of approximately RMB 174,710,000 in 2024, up 15.6% from RMB 151,177,000 in 2023[18] - The dental clinic services revenue grew to approximately RMB 10,257,000 in 2024, a 5.8% increase from RMB 9,695,000 in 2023[23] - The sales of medical equipment and dental materials surged by approximately RMB 6,229,000 or 103% to RMB 12,274,000 in 2024 compared to RMB 6,045,000 in 2023[23] Acquisitions and Expansion - The company plans to add three new dental medical institutions through new construction and acquisitions, expanding its service network[11] - The company completed the acquisition of Hong Kong Shengke Holdings Limited in 2023, expanding its presence in the dental care industry[19] - The company completed the acquisition of all shares of Hong Kong Tai Hing Holdings Limited and its subsidiaries in January 2024 [35] - The company intends to acquire at least 51% of a medical management company in the Guangdong-Hong Kong-Macao Greater Bay Area to explore market potential[11] Innovation and Development - The company is developing an online oral health service platform to provide remote diagnosis and consultation services[11] - The company will invest in a pulp cell project in Beijing, aiming to innovate treatment paths for oral diseases[12] - The company is developing an AI system for the full lifecycle management of periodontal disease and pulp cell treatment, showcasing its innovative potential[15] Employee and Compensation - The total employee compensation for 2024 is approximately RMB 51,161,000, an increase from RMB 42,001,000 in 2023, with 608 full-time employees as of December 31, 2024 [44] - The company has a total of 2 senior management members earning between 0 to HKD 1,000,000, and 1 member earning between HKD 1,000,000 to HKD 1,500,000[107] Corporate Governance - The company has maintained high standards of corporate governance, adhering to the principles and code provisions of the corporate governance code as per GEM listing rules[125] - The board consists of three independent non-executive directors, accounting for over one-third of the board members, ensuring fair opinions on strategy and performance[127] - The company has established a mechanism for assessing board independence, with annual reviews conducted to ensure effective independent judgment and shareholder protection[136] - The board has formed three committees: the Remuneration Committee, the Nomination Committee, and the Audit Committee, each with clear written terms of reference[138] Environmental, Social, and Governance (ESG) - The company has set environmental goals and implemented the latest ESG-related policies and guidelines to comply with applicable laws and regulations[179] - The company emphasizes the importance of sustainability as a key to ongoing success and integrates ESG into its risk management system[178] - The company has established an environmental management system certified by ISO 14001:2015[192] - The company is committed to improving its ESG performance and creating greater value for the community[190] Risk Management - The group continues to face risks related to currency fluctuations between RMB and USD, which may impact future revenue and profit margins[65] - The company has not established any formal foreign exchange hedging policy to manage currency risks due to the limited ability to reduce foreign exchange risk [42] Shareholder Communication - The company has adopted a shareholder communication policy to ensure timely and equal access to information for shareholders and potential investors[170] - The company has established multiple channels for communication with shareholders, including printed corporate communications and regular announcements through the stock exchange[172]
中国口腔产业(08406) - 2024 - 年度业绩
2025-03-31 14:36
Financial Performance - The company's revenue for the year ended December 31, 2024, was RMB 230,959,000, an increase of 38.4% compared to RMB 166,917,000 in 2023[4] - Gross profit for the same period was RMB 37,251,000, representing a gross margin of 16.1%, up from RMB 27,035,000 in 2023[4] - The company reported a net loss of RMB 16,439,000 for the year, an improvement from a net loss of RMB 18,626,000 in the previous year, indicating a reduction in losses by 6.4%[4] - The company's total comprehensive loss for the year was RMB 15,913,000, a decrease from RMB 18,483,000 in the previous year, indicating a 13.8% improvement[4] - The basic loss per share for the year was RMB 1.5, compared to RMB 1.9 in 2023, reflecting a reduction in loss per share by 21.1%[4] - The group reported a pre-tax loss of RMB 16,439,000 for the year, indicating challenges in profitability despite revenue growth[17] - The net loss for the year was approximately RMB 16,439,000, a decrease of about RMB 2,187,000 or 11.7% from 2023 (approximately RMB 18,626,000)[51] Expenses and Costs - Distribution and selling expenses increased to RMB 26,296,000 from RMB 20,174,000, reflecting a rise of 30.5% year-over-year[4] - The total depreciation and amortization expenses for 2024 amounted to RMB 1,543,000, a decrease from RMB 4,741,000 in 2023[28] - Administrative expenses were approximately RMB 20,393,000 in 2024, an increase of about RMB 800,000 or 4.1% compared to 2023 (approximately RMB 19,593,000)[47] - The group recognized a goodwill impairment loss of approximately RMB 7,200,000 related to the dental clinic business as of December 31, 2024[49] - Financing costs decreased to approximately RMB 753,000 in 2024, a reduction of about RMB 262,000 or 25.8% compared to 2023 (approximately RMB 1,015,000)[50] Assets and Liabilities - Total assets increased from RMB 183,775,000 in 2023 to RMB 202,459,000 in 2024, representing an increase of 10.5%[5] - Non-current assets rose from RMB 11,934,000 in 2023 to RMB 19,238,000 in 2024, marking a significant increase of 61.5%[5] - Current assets increased from RMB 164,537,000 in 2023 to RMB 177,058,000 in 2024, reflecting a growth of 7.6%[5] - The company's net asset value grew from RMB 104,665,000 in 2023 to RMB 107,138,000 in 2024, an increase of 2.3%[6] - The company's lease liabilities increased from RMB 2,616,000 in 2023 to RMB 5,263,000 in 2024, an increase of 101.5%[5] - Total liabilities classified as held for sale rose from RMB 20,189,000 in 2023 to RMB 20,189,000 in 2024, indicating a stable position[5] - The company's equity attributable to owners increased from RMB 10,059,000 in 2023 to RMB 14,379,000 in 2024, a growth of 42.5%[6] Revenue Segments - The sales of inflatable products and related accessories generated RMB 170,790,000, up from RMB 150,860,000, reflecting a growth of 13.5%[14] - The dental clinic services segment reported revenue of RMB 10,257,000, an increase from RMB 9,695,000, representing a growth of 5.8%[14] - The yarn and polyester business generated revenue of RMB 33,718,000, contributing to the overall revenue growth[17] - Revenue from the inflatable products business was approximately RMB 174,710,000, up RMB 23,533,000 or 15.6% from RMB 151,177,000 in 2023[41] - Revenue from dental clinic services was approximately RMB 10,257,000, an increase of about RMB 562,000 or 5.8% compared to RMB 9,695,000 in 2023[41] - Sales of medical equipment and dental materials reached approximately RMB 12,274,000, up RMB 6,229,000 or 103% from RMB 6,045,000 in 2023[41] - Revenue from external customers in 2024 reached RMB 230,959,000, an increase of 38.4% compared to RMB 166,917,000 in 2023[24] Strategic Initiatives - The company aims to expand its market presence and enhance product offerings in the upcoming fiscal year, focusing on new technologies and strategic partnerships[4] - Future guidance indicates a continued focus on cost management and operational efficiency to improve profitability metrics moving forward[4] - The group completed the acquisition of Hong Kong Tai Hing Holdings Limited, expanding its operations into the sales of yarn and polyester[16] - The group completed the acquisition of all shares of Hong Kong Tai Hing Holdings Limited and its subsidiaries in January 2024[55] Risks and Challenges - The company remains cautious about geopolitical tensions and trade wars impacting its business while maintaining a strategic position to seize future opportunities[40] - The group faces significant foreign exchange risk as most revenues are denominated in USD while production costs are in RMB, which may impact business performance[61] - The group has not established any formal foreign exchange hedging policy, limiting its ability to mitigate foreign exchange risks due to the non-convertibility of the RMB[62] Employee and Governance - As of December 31, 2024, the group employed 608 full-time employees, an increase from 544 in 2023, with total employee compensation amounting to approximately RMB 51,161,000, up from RMB 42,001,000 in 2023[64] - The company confirmed that all directors have adhered to the trading standards and the code of conduct for securities transactions as per GEM Listing Rules[70] - The audit committee, consisting of four independent non-executive directors, has reviewed the financial reporting procedures and internal control processes for the year ending December 31, 2024[74] - The financial statements for the year ending December 31, 2024, have been confirmed by the auditor, Guo Wei CPA Limited, to be consistent with the amounts reported[75]
中国口腔产业(08406) - 2024 - 中期财报
2024-08-28 13:54
Financial Performance - The company reported revenue of RMB 124.66 million for the six months ended June 30, 2024, representing a 31.3% increase from RMB 94.88 million in the same period of 2023[7]. - Gross profit for the same period was RMB 23.40 million, up 75.8% from RMB 13.34 million year-on-year[7]. - The net profit for the period was RMB 0.88 million, a significant recovery from a net loss of RMB 3.58 million in the previous year[7]. - The company achieved a basic and diluted earnings per share of RMB 0.08, recovering from a loss per share of RMB 0.37 in the previous year[7]. - The pre-tax profit for the six months ended June 30, 2024, was RMB 1,151,000, compared to a pre-tax loss of RMB 3,359,000 for the same period in 2023[19][20]. - The net profit attributable to the company's owners for the six months ended June 30, 2024, was RMB 880,000, compared to a loss of RMB 3.58 million in the same period of 2023[33]. - The group reported a profit of approximately RMB 880,000, an increase of about RMB 4,464,000 or 124.6% compared to a loss in the corresponding period in 2023 (RMB 3,584,000)[53]. Assets and Liabilities - Total assets increased to RMB 236.17 million as of June 30, 2024, compared to RMB 183.78 million at the end of 2023, marking a growth of 28.5%[8]. - The company's current liabilities rose to RMB 100.84 million, up from RMB 67.47 million at the end of 2023, indicating increased operational activity[8]. - The total liabilities as of June 30, 2024, were RMB 110,048,000, up from RMB 79,110,000 as of December 31, 2023, reflecting an increase of approximately 39.1%[22][23]. - The net asset value increased to RMB 126.12 million as of June 30, 2024, compared to RMB 104.67 million at the end of 2023, reflecting a growth of 20.5%[9]. - As of June 30, 2024, the total equity attributable to owners of the company reached RMB 126,121 thousand, an increase from RMB 123,148 thousand as of January 1, 2023, reflecting a growth of approximately 2.4%[10]. - As of June 30, 2024, the total equity attributable to the owners of the company was approximately RMB 126,121,000, up from RMB 104,665,000 as of December 31, 2023[55]. Cash Flow and Operating Activities - The net cash generated from operating activities for the six months ended June 30, 2024, was RMB 2,291 thousand, compared to RMB 22,683 thousand for the same period in 2023, indicating a significant decline of approximately 89.9%[11]. - The company’s operating cash flow before changes in working capital was RMB 2,331 thousand for the six months ended June 30, 2024, compared to a negative RMB 735 thousand for the same period in 2023[11]. - Cash and cash equivalents at the end of June 30, 2024, amounted to RMB 72,039 thousand, an increase from RMB 69,923 thousand at the end of June 30, 2023, representing a growth of approximately 3.0%[11]. - The company’s investment activities generated a net cash inflow of RMB 16,850 thousand for the six months ended June 30, 2024, compared to RMB 19,204 thousand for the same period in 2023, reflecting a decrease of approximately 6.9%[11]. Revenue Breakdown - The revenue breakdown includes RMB 103,126,000 from inflatable products, RMB 7,092,000 from dental clinic services, and RMB 14,003,000 from yarn and polyester sales[25]. - Revenue from the sale of inflatable products and related accessories was approximately RMB 103.57 million, up RMB 13.77 million or 15.3% from RMB 89.79 million in the previous year[46]. - Revenue from dental clinic services increased to approximately RMB 7.09 million, a rise of RMB 2.00 million or 39.3% compared to RMB 5.09 million in 2023[46]. - For the six months ended June 30, 2024, the total revenue from external customers was RMB 124,660,000, representing an increase from RMB 94,882,000 for the same period in 2023, which is a growth of approximately 31.3%[25]. Expenses and Costs - The cost of sales for the period was approximately RMB 101.26 million, an increase of RMB 19.71 million or 24.2% from RMB 81.54 million in the same period last year[47]. - Distribution and selling expenses amounted to approximately RMB 12,483,000, an increase of about RMB 2,167,000 or 21.0% compared to the corresponding period in 2023 (RMB 10,316,000)[50]. - Administrative expenses were approximately RMB 10,466,000, an increase of about RMB 1,278,000 or 13.9% compared to the corresponding period in 2023 (RMB 9,188,000)[51]. - Financial costs were approximately RMB 558,000, a decrease of about RMB 77,000 or 12.1% compared to the corresponding period in 2023 (RMB 635,000) mainly due to reduced interest on lease liabilities[52]. Strategic Initiatives - The company plans to expand its market presence and invest in new product development to drive future growth[7]. - The company is focusing on enhancing its distribution and sales strategies to improve operational efficiency and profitability[7]. - The company has maintained its risk management policies without significant changes since the end of the last fiscal year[16]. - The company aims to attract and retain valuable talent through its stock option plan, which is designed to reward contributions to the group[66]. Corporate Governance - The audit committee, consisting of three independent non-executive directors, has reviewed the unaudited financial results for the period and confirmed compliance with applicable accounting standards and GEM listing rules[71]. - The company has adhered to the corporate governance code as per GEM listing rules during the reporting period[70]. - The board of directors has confirmed compliance with the trading standards for securities transactions during the reporting period[68]. Acquisitions and Investments - The company acquired 100% equity of Hong Kong Shengke Holdings Limited and Hong Kong Taixing Holdings Limited in 2023 and 2024, respectively, expanding its business into dental clinic operations and polyester sales[45]. - The group completed the acquisition of 100% equity in Hong Kong Tai Hing Holdings Limited in January 2024, which engages in yarn and polyester sales in China[56]. - The company reported no acquisitions of intangible assets during the period, compared to RMB 27,000 in the previous year[36]. Employee Information - As of June 30, 2024, the group had 567 full-time employees, with total employee compensation of approximately RMB 26,096,000, an increase from RMB 22,530,000 in 2023[62].
中国口腔产业(08406) - 2024 - 中期业绩
2024-08-28 13:50
Financial Performance - The company reported its interim results for the six months ending June 30, 2024, with a focus on financial performance and operational metrics[1]. - The company's revenue for the six months ended June 30, 2024, was RMB 124.66 million, an increase of 31.3% compared to RMB 94.88 million for the same period in 2023[9]. - Gross profit for the same period was RMB 23.40 million, up from RMB 13.34 million, reflecting a gross margin improvement[9]. - The net profit for the period was RMB 0.88 million, a significant recovery from a net loss of RMB 3.58 million in the previous year[9]. - The company reported a total comprehensive income of RMB 1.84 million for the period, compared to a total comprehensive loss of RMB 2.29 million in the same period last year[9]. - The pre-tax profit for the six months ended June 30, 2024, was RMB 1,151,000, compared to a pre-tax loss of RMB 3,359,000 for the same period in 2023, indicating a significant turnaround[21][22]. - The company reported a profit of RMB 880 thousand for the six months ended June 30, 2024, compared to a loss of RMB 3,584 thousand in the same period of 2023[35]. - The overall gross margin for the period was approximately 18.8%, an increase of 4.7% from 14.1% in the previous year[50]. Revenue Breakdown - Revenue from the inflatable products segment was RMB 103,565,000, accounting for 83% of total revenue, while the dental clinic segment generated RMB 7,092,000, and the yarn and polyester segment contributed RMB 14,003,000[21]. - Revenue from external customers in North America was RMB 78,594 thousand, representing a 13.5% increase from RMB 69,192 thousand in the previous year[29]. - Revenue from the sale of inflatable products and related accessories was approximately RMB 103.57 million, up RMB 13.77 million or 15.3% from RMB 89.79 million in the previous year[48]. Assets and Liabilities - The total assets increased to RMB 236.17 million as of June 30, 2024, compared to RMB 183.78 million at the end of 2023, representing a growth of 28.5%[10]. - Total liabilities increased to RMB 110,048 thousand as of June 30, 2024, compared to RMB 79,110 thousand at the end of 2023[24][25]. - Current liabilities rose to RMB 100.84 million, up from RMB 67.47 million at the end of 2023, indicating increased operational activity[10]. - Trade receivables as of June 30, 2024, were RMB 40,652 thousand, significantly higher than RMB 17,707 thousand at the end of 2023[39]. - The total current assets as of June 30, 2024, amounted to approximately RMB 126.12 million, compared to RMB 104.67 million on December 31, 2023[57]. Corporate Governance and Compliance - The company emphasizes compliance with the GEM listing rules and the importance of accurate and complete disclosures[2]. - The board of directors has confirmed the accuracy of the information presented, ensuring no misleading or fraudulent elements are included[2]. - The company is committed to transparency and accountability in its financial reporting and corporate governance practices[2]. - The Audit Committee was established on June 20, 2017, consisting of three independent non-executive directors, with Ms. Lian Jingyu as the chairperson[73]. - The Audit Committee reviewed the unaudited financial performance for the six months ending June 30, 2024, ensuring compliance with applicable accounting standards and GEM listing rules[73]. Future Outlook - Future outlook and performance guidance will be addressed in the full interim report, which is anticipated to be sent to shareholders[1]. - Market expansion strategies and potential mergers or acquisitions are likely to be discussed in the upcoming full report[1]. - The company is actively engaged in new product and technology development, although specific details were not provided in the content[1]. - The company is focusing on expanding its market presence and enhancing its product offerings, although specific new products or technologies were not detailed in the report[9]. Employee and Compensation - The total employee compensation for the six months ended June 30, 2024, was approximately RMB 26,096,000, an increase from RMB 22,530,000 in the same period of 2023[64]. - As of June 30, 2024, the company had 567 full-time employees, up from 544 as of December 31, 2023[64]. Financial Management - The company has not made any significant changes to its liquidity risk management policies since the end of the previous fiscal year[18]. - The financial risk management policies remain unchanged since the end of the last fiscal year, addressing interest rate risk, credit risk, and liquidity risk[17]. - The company faces foreign exchange risk due to revenue being primarily denominated in USD while production costs are in RMB, with no formal foreign exchange hedging policy in place[62]. Miscellaneous - The company did not declare any interim dividend for the six months ended June 30, 2024, consistent with the previous year[36]. - The company has not granted any stock options under its stock option plan since its adoption on November 15, 2017[68]. - No purchases, sales, or redemptions of the company's securities occurred during the reporting period[71].
中国口腔产业(08406) - 2023 - 年度财报
2024-04-29 08:42
Financial Performance - The company reported a total revenue of approximately RMB 166,917,000 for 2023, a decrease of about RMB 45,602,000 or 21.5% compared to 2022[17]. - Revenue from the sale of inflatable products and related accessories was approximately RMB 151,177,000, down RMB 61,342,000 or 28.9% from RMB 212,519,000 in 2022[12]. - The company generated revenue of RMB 9,695,000 from dental clinic services and RMB 6,045,000 from the sale of medical equipment and dental materials, accounting for approximately 5.8% and 3.6% of total revenue, respectively[12]. - The group recorded revenue from overseas customers of approximately RMB 140,136,000, accounting for 84.0% of total revenue, a decrease from 95.3% in the previous year[79]. - Total revenue from the group's top five customers contributed approximately 60.7% of total revenue, slightly down from 60.8% in the previous year[79]. Profit and Loss - The company incurred a loss of approximately RMB 18,626,000 for the year, a reduction of about RMB 16,225,000 or 46.6% compared to a loss of RMB 34,851,000 in 2022[12]. - The group reported a loss of approximately RMB 18,626,000 for the year, a decrease of approximately RMB 16,225,000 or 46.6% compared to the loss of RMB 34,851,000 in 2022[29]. - Other income and gains totaled approximately RMB 5,468,000 in 2023, a decrease of approximately RMB 3,345,000 or 38.0% from 2022 (RMB 8,813,000) primarily due to reduced rental income and subsidies[23]. Cost and Expenses - The cost of sales for 2023 was approximately RMB 139,882,000, a decrease of about RMB 55,066,000 or 28.2% from RMB 194,948,000 in 2022[19]. - Distribution and selling expenses amounted to approximately RMB 20,174,000 in 2023, a decrease of approximately RMB 3,287,000 or 14.0% from 2022 (RMB 23,461,000)[24]. - Administrative expenses were approximately RMB 19,593,000 in 2023, down by approximately RMB 4,572,000 or 18.9% from 2022 (RMB 24,165,000)[25]. Acquisitions and Investments - The company completed the acquisition of Hong Kong Shengke Holdings Limited in January 2023, which is expected to provide new revenue sources in the dental care industry[16]. - The group completed the acquisition of Hong Kong Shengke Holdings Limited and its subsidiaries in January 2023[37]. - The group plans to acquire Hong Kong Taixing Holdings Limited and its subsidiaries for HKD 25,600,000, with the transaction completed on January 29, 2024[42]. - The company’s management is still determining the financial impact of the acquisition of Hong Kong Tai Hing Holdings Limited as of the approval date of the financial statements[129]. Equity and Capital - As of December 31, 2023, the group's total equity attributable to owners was approximately RMB 104,665,000, down from RMB 123,148,000 in 2022[31]. - Capital expenditure for the year was approximately RMB 1,842,000, an increase from RMB 616,000 in 2022[32]. - The company’s distributable reserves as of December 31, 2023, were approximately RMB 34,225,000, down from RMB 61,438,000 in 2022[94]. Employee and Compensation - The total employee compensation for the group in 2023 was approximately RMB 42,001,000, down from approximately RMB 50,993,000 in 2022, with a total of 544 full-time employees as of December 31, 2023[48]. - The company's remuneration policy includes fixed components (base salary) and variable components (discretionary bonuses and other rewards)[120]. - The board of directors and senior management's remuneration is reviewed annually by the remuneration committee[120]. Corporate Governance - The board of directors is committed to maintaining high standards of corporate governance to protect shareholder interests and enhance group performance[141]. - The company has established a referral agreement with Mango Financial Limited to introduce potential clients for the bond issuance[130]. - The audit committee held 5 meetings during the year to review the company's annual and interim performance, ensuring compliance with applicable accounting standards and GEM listing rules[159]. - The board aims to maintain at least 66.7% female representation among directors, 50% among senior management, and 62.7% among other employees[189]. Risk Management - The group faces risks related to fluctuations in the RMB to USD exchange rate and potential product liability claims[73]. - The group has not established an internal audit function as of December 31, 2023, but will continue to evaluate the need for such a function annually[176]. - There were no significant legal or regulatory non-compliance issues affecting the group's business operations during the reporting period[196]. Quality and Standards - The company emphasizes high-quality standards and strict quality control procedures in its production processes[16]. - The group emphasizes quality control, product safety, and customer service as critical to maintaining customer trust[79]. - The company believes that its product design and development capabilities will enhance competitiveness through product differentiation and innovation[16]. Shareholder Communication - The company has established multiple channels for shareholder communication to ensure timely and unbiased information dissemination[197]. - The company confirmed that it has maintained the public float required by GEM listing rules as of the date of the annual report[135].
中国口腔产业(08406) - 2023 - 年度业绩
2024-03-28 13:31
Financial Performance - For the year ended December 31, 2023, the company's revenue was RMB 166,917,000, a decrease of 21.5% compared to RMB 212,519,000 in 2022[4] - The gross profit for the same period was RMB 27,035,000, representing a significant increase of 53.5% from RMB 17,571,000 in the previous year[4] - The net loss for the year was RMB 18,626,000, an improvement of 46.6% compared to a net loss of RMB 34,851,000 in 2022[4] - Total revenue for the year 2023 was RMB 166,917,000, a decrease of 21.5% from RMB 212,519,000 in 2022[22] - Revenue from inflatable products and related accessories was RMB 150,860,000, down from RMB 212,051,000 in the previous year, representing a decline of 29%[22] - The group reported a total loss before tax of RMB 18,408,000 for the year 2023, compared to a loss of RMB 35,768,000 in 2022, indicating an improvement[26] - The group reported a net loss attributable to owners of the company of RMB 18,626,000 in 2023, an improvement from a loss of RMB 34,851,000 in 2022[42] - The company reported a significant impairment loss on non-financial assets of RMB 10,223,000 in 2023, compared to RMB 12,215,000 in 2022, a decrease of 16.3%[33] - Other income and gains for 2023 totaled approximately RMB 5,468,000, a decrease of about RMB 3,345,000 or 38.0% from RMB 8,813,000 in 2022[55] Assets and Liabilities - The company's total assets as of December 31, 2023, were RMB 183,775,000, a decrease from RMB 190,846,000 in 2022[6] - Current assets increased to RMB 164,537,000 from RMB 152,522,000 in the previous year, indicating a growth of 7.0%[6] - The total equity attributable to owners decreased to RMB 104,665,000 from RMB 123,148,000, a decline of 15.0%[7] - The group’s total liabilities amounted to RMB 79,110,000, with RMB 60,486,000 attributed to reportable segments[29] - Trade receivables decreased to RMB 17,707,000 in 2023 from RMB 22,738,000 in 2022, indicating a reduction of 22.1%[44] Cash Flow and Financing - The company’s cash and bank balances rose to RMB 56,323,000, up from RMB 29,385,000 in 2022, reflecting a significant increase of 91.7%[6] - Interest income from bank deposits for the year was RMB 753,000, an increase from RMB 56,000 in the previous year[26] - Interest income from bank deposits rose to RMB 753,000 in 2023 compared to RMB 56,000 in 2022, marking a significant increase of 1,241.1%[38] - The company’s financing costs, specifically lease liabilities interest, decreased to RMB 1,015,000 in 2023 from RMB 1,607,000 in 2022, a reduction of 37%[39] - The current ratio as of December 31, 2023, was approximately 2.44, down from 2.83 in 2022, indicating a decrease in liquidity[63] Business Operations - The company has been focusing on the manufacturing and sales of inflatable products and dental clinic services, indicating a strategic emphasis on these sectors[11] - The dental clinic services segment generated revenue of RMB 9,695,000, while sales of medical equipment and dental materials contributed RMB 1,450,000 and RMB 4,595,000 respectively[22] - The company completed the acquisition of Hong Kong Shengke Holdings Limited in January 2023, entering the dental clinic services sector, which is expected to provide new revenue streams[50] Employee and Governance - As of December 31, 2023, the company had 544 full-time employees, a decrease from 571 in 2022, with total employee compensation amounting to approximately RMB 42,001,000, down from RMB 50,993,000 in 2022[74] - The company has confirmed compliance with the GEM Listing Rules regarding the trading of securities by directors, with no reported violations in 2023[82] - The company has adhered to the corporate governance code as per the GEM Listing Rules, confirming compliance in 2023[86] - The audit committee was established on June 20, 2017, and consists of three independent non-executive directors as of 2023[87] - The audit committee's main responsibility is to review and supervise the group's financial reporting and internal control procedures[87] Future Outlook - The company plans to apply all other revised Hong Kong Financial Reporting Standards in the foreseeable future without significant impact on the consolidated financial statements[17] - The company has proposed to issue bonds with a total principal amount of up to HKD 40,000,000 at a 5% coupon rate over 36 months, with an introduction fee of HKD 2,000,000 payable to the agent[70] Miscellaneous - The company has not established any formal foreign exchange hedging policy, which limits its ability to mitigate foreign exchange risks due to the non-convertibility of the Renminbi[72] - No credit loss provisions were recognized for trade and other receivables in 2023, compared to RMB 547,000 in provisions in 2022, indicating a stable collection history from customers[73] - The company has not granted any stock options under its stock option plan since its adoption on November 15, 2017[80] - The annual general meeting is scheduled for June 21, 2024, with a suspension of share transfer registration from June 18 to June 21, 2024[85] - The consolidated financial statements for the year ended December 31, 2023, have been reviewed by the auditors, confirming consistency with the audited financial statements[89] - The board expresses gratitude to the management and staff for their dedication and to shareholders, suppliers, customers, and banks for their ongoing support[91] - The announcement will be published on the Hong Kong Stock Exchange website for at least seven days from the date of publication[92]
中国口腔产业(08406) - 2023 Q3 - 季度财报
2023-11-13 10:41
Financial Performance - Revenue for the three months ended September 30, 2023, was RMB 26,481,000, a decrease of 31.3% compared to RMB 38,594,000 for the same period in 2022[4] - Gross profit for the nine months ended September 30, 2023, was RMB 17,843,000, down 14.7% from RMB 20,894,000 in the same period of 2022[4] - The net loss for the nine months ended September 30, 2023, was RMB 8,526,000, compared to a net loss of RMB 8,347,000 for the same period in 2022, indicating a slight increase in losses[4] - The company reported a basic and diluted loss per share of RMB 0.89 for the nine months ended September 30, 2023, compared to RMB 1.04 for the same period in 2022[4] - The company’s total revenue for the nine months ended September 30, 2023, was RMB 121,363,000, down 33.6% from RMB 182,495,000 in the same period of 2022[4] - The adjusted pre-tax loss for the group was RMB 8,236,000 for the first nine months of 2023, compared to a loss of RMB 7,765,000 in the same period of 2022[15] - The company reported a net loss attributable to shareholders of RMB 8,526,000 for the first nine months of 2023, compared to a loss of RMB 8,347,000 in the same period of 2022[26] - The group recorded a loss of approximately RMB 8,526,000 for the period, a decrease of 2.14% compared to a loss of RMB 8,347,000 in the same period of 2022[38] Revenue Breakdown - Revenue from inflatable products decreased to RMB 113,022,000 in Q3 2023 from RMB 182,575,000 in Q3 2022, representing a decline of 38.3%[15] - Revenue from dental clinic services was RMB 8,362,000 in the first nine months of 2023, with no revenue reported in the same period of 2022[15] - Revenue from external customers in China increased to RMB 15,483,000 in the first nine months of 2023, compared to RMB 8,917,000 in the same period of 2022, an increase of 73.5%[19] - Revenue from the sale of inflatable products and related accessories was approximately RMB 113,001,000, down RMB 69,494,000 or 38.1% from RMB 182,495,000 in the same period last year[30] - The group's revenue for the period was approximately RMB 121,363,000, a decrease of about RMB 61,132,000 or 33.5% compared to RMB 182,945,000 in the corresponding period of 2022[30] Expenses - Distribution and selling expenses for the nine months ended September 30, 2023, were RMB 15,183,000, a decrease of 22.9% from RMB 19,687,000 in the same period of 2022[4] - Administrative expenses for the nine months ended September 30, 2023, were RMB 13,955,000, down 8.1% from RMB 15,195,000 in the same period of 2022[4] - Distribution and selling expenses amounted to approximately RMB 15,183,000, a decrease of about RMB 4,504,000 or 22.9% from RMB 19,687,000 in the same period of 2022[35] - Administrative expenses were approximately RMB 13,955,000, a decrease of about RMB 1,240,000 or 8.2% compared to RMB 15,195,000 in the same period last year[36] Equity and Dividends - Total equity as of September 30, 2023, was RMB 116,216,000, a decrease from RMB 118,709,000 as of January 1, 2022[5] - The company did not recommend any dividend payments during the period, consistent with the previous year[27] - The board decided not to declare any dividends for the period[40] Strategic Initiatives - The company continues to focus on the dental industry and aims to enhance its market position through strategic initiatives and product development[9] - The company aims to enhance competitiveness through product differentiation and innovation in the health sector[29] - In January 2023, the company completed the acquisition of all shares of Hong Kong Shengke Holdings Limited and its wholly-owned subsidiary Guangzhou Lide Dental Clinic[41] - The company completed the acquisition of Hong Kong Shengke Holdings Limited in January 2023, expanding into the dental care industry and creating new revenue streams[29] Governance and Compliance - The Audit Committee was established on June 20, 2017, chaired by independent non-executive director Ms. Lian Jingyu, ensuring compliance with GEM listing rules and corporate governance codes[54] - The unaudited condensed consolidated financial statements have been reviewed by the Audit Committee, confirming adherence to applicable accounting standards and sufficient disclosure[54] - The board of directors includes executive directors Ms. Yan Ping, Mr. Liu Yaoguang, and Mr. Xiao Jiansheng, along with independent non-executive directors[55]
中国口腔产业(08406) - 2023 Q3 - 季度业绩
2023-11-13 10:31
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責,對其準確性或完 整性亦不發表任何聲明,並明確表示,概不對因本公告全部或任何部份內容而產生或因倚賴該等內 容而引致的任何損失承擔任何責任。 China Oral Industry Group Holdings Limited 中 國 口 腔 產 業 集 團 控 股 有 限 公 司 (於開曼群島註冊成立的有限公司) (股份代號:8406) 截至二零二三年九月三十日止九個月之 第三季度業績公告 香港聯合交易所有限公司(「聯交所」)GEM的特色 GEM的定位,乃為中小型公司提供一個上市的市場,此等公司相比起其他在聯交所上市的公司可能 帶有較高投資風險。有意投資的人士應了解投資於該等公司的潛在風險,並應經過審慎周詳考慮後 方作出投資決定。 由於GEM上市公司一般為中小型公司,於GEM買賣的證券可能會較於主板買賣的證券承受較大的市 場波動風險,同時無法保證於GEM買賣的證券會有高流通量的市場。 本公告之資料乃遵照聯交所GEM證券上市規則(「GEM上市規則」)而刊載,旨在提供有關中國口腔產 業集團控股有限公司(「本公司」及連同其附屬公司,統稱為「本集團 ...
中国口腔产业(08406) - 2023 - 中期财报
2023-08-14 14:51
Financial Performance - For the six months ended June 30, 2023, the company reported revenue of RMB 94,882,000, a decrease of 34% compared to RMB 143,901,000 for the same period in 2022[9]. - The gross profit for the same period was RMB 13,340,000, down 26% from RMB 17,989,000 in 2022, resulting in a gross margin of approximately 14.1%[9]. - The company incurred a loss before tax of RMB 3,359,000 for the six months ended June 30, 2023, compared to a loss of RMB 2,350,000 in the prior year, indicating a worsening financial performance[9]. - The total comprehensive loss for the period was RMB 2,287,000, compared to a loss of RMB 400,000 in the same period of 2022[9]. - The company reported a basic and diluted loss per share of RMB 0.37 for the six months ended June 30, 2023, compared to RMB 0.36 in the same period of 2022[9]. - The company reported a loss of RMB 3,584,000 for the six months ended June 30, 2023, compared to a loss of RMB 2,884,000 for the same period in 2022, reflecting an increase in losses of approximately 24.2%[14]. - The company’s total comprehensive income for the six months ended June 30, 2023, was a loss of RMB 2,287,000, compared to a loss of RMB 400,000 for the same period in 2022, indicating a worsening of approximately 471.8%[14]. Assets and Liabilities - As of June 30, 2023, the company's total assets amounted to RMB 184,914,000, a decrease from RMB 190,846,000 at the end of 2022[11]. - As of June 30, 2023, the company's non-current liabilities decreased to RMB 11,898,000 from RMB 13,846,000 as of December 31, 2022, representing a reduction of approximately 14.0%[12]. - The net asset value as of June 30, 2023, was RMB 120,861,000, down from RMB 123,148,000 at the end of 2022, indicating a decline of about 1.9%[12]. - The total liabilities as of June 30, 2023, were RMB 64,053,000, down from RMB 67,698,000 as of December 31, 2022[30]. - The total trade receivables as of June 30, 2023, were RMB 23,165,000, slightly down from RMB 23,579,000 as of December 31, 2022, a decrease of 1.8%[49]. - The total trade payables as of June 30, 2023, were RMB 17,990,000, down 20.0% from RMB 22,503,000 as of December 31, 2022[52]. Cash Flow and Liquidity - The company's cash and bank balances increased significantly to RMB 69,923,000 from RMB 29,385,000 at the end of 2022, indicating improved liquidity[11]. - Operating cash flow for the six months ended June 30, 2023, was RMB 22,683,000, significantly higher than RMB 9,749,000 for the same period in 2022, marking an increase of about 132.5%[17]. - The company’s cash and cash equivalents increased to RMB 69,923,000 as of June 30, 2023, from RMB 34,479,000 at the end of 2022, representing a growth of approximately 102.5%[17]. - The company’s financing cash outflow for the six months ended June 30, 2023, was RMB 2,645,000, slightly lower than RMB 2,782,000 for the same period in 2022[17]. Revenue Segments - Revenue from the sale of inflatable products and related accessories was approximately RMB 89,791,000, down RMB 54,110,000 or 34.6% from the previous year's RMB 143,901,000[57]. - Revenue from dental clinic services was approximately RMB 5,091,000, accounting for about 5.4% of total revenue[57]. - The segment revenue from the sale of inflatable products was RMB 89,804,000 for the six months ended June 30, 2023, down from RMB 143,970,000 in the same period of 2022, representing a decline of 37.6%[30]. - The segment performance for the inflatable products showed a loss of RMB 2,929,000 for the six months ended June 30, 2023, compared to a profit of RMB 1,194,000 in the same period of 2022[30]. Expenses - Distribution and selling expenses totaled approximately RMB 10,316,000, a decrease of RMB 2,860,000 or 21.7% from RMB 13,176,000 in the previous year[62]. - Administrative expenses for the period were approximately RMB 9,188,000, down RMB 891,000 or 8.8% from RMB 10,079,000 in the corresponding period of 2022[63]. - The cost of goods sold for the six months ended June 30, 2023, was RMB 81,542,000, down 35.2% from RMB 125,912,000 in the same period of 2022[42]. Corporate Governance and Compliance - The audit committee, consisting of three independent non-executive directors, reviewed the unaudited financial results for the six months ended June 30, 2023, ensuring compliance with applicable accounting standards[89]. - The company has adhered to the corporate governance code as per GEM Listing Rules during the reporting period[87]. - The company has complied with the trading standards for directors as per GEM Listing Rules during the reporting period[85]. Employee Information - As of June 30, 2023, the group had 567 full-time employees, a decrease from 571 employees as of December 31, 2022[77]. - Total employee compensation for the six months ended June 30, 2023, was approximately RMB 22,530,000, down from approximately RMB 31,724,000 in the same period of 2022[77]. Shareholder Information - Ms. Yan Ping holds a 44.23% equity interest in the company, representing 424,560,000 shares out of 960,000,000 issued shares as of June 30, 2023[79]. - There were no other individuals or entities holding more than 5% of the issued share capital of the company as of June 30, 2023[81]. Other Information - The company did not recommend any interim dividend for the six months ended June 30, 2023, consistent with the previous year[45]. - The company has not granted any stock options under the stock option plan since its adoption on November 15, 2017[83]. - The company has established a stock option plan to provide additional incentives to qualified participants for their contributions[82].
中国口腔产业(08406) - 2023 - 中期业绩
2023-08-14 14:40
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責,對其準確性或完 整性亦不發表任何聲明,並明確表示,概不對因本公告全部或任何部份內容而產生或因倚賴該等內 容而引致的任何損失承擔任何責任。 China Oral Industry Group Holdings Limited 中 國 口 腔 產 業 集 團 控 股 有 限 公 司 (於開曼群島註冊成立的有限公司) (股份代號:8406) 截至二零二三年六月三十日止六個月 中期業績公告 香港聯合交易所有限公司(「聯交所」)GEM的特色 GEM的定位,乃為相比起其他於聯交所上市的公司帶有較高投資風險的中小型公司提供一個上市的 市場。有意投資的人士應了解投資於該等公司的潛在風險,並應經過審慎周詳考慮後方作出投資決 定。 由於GEM上市公司一般為中小型公司,於GEM買賣的證券可能會較於主板買賣的證券承受較大的市 場波動風險,同時無法保證於GEM買賣的證券會有高流通量的市場。 本公告之資料乃遵照聯交所GEM證券上市規則(「GEM上市規則」)而刊載,旨在提供有關中國口腔 產業集團控股有限公司(前稱為合寶豐年控股有限公司)(「本公司」,連同其附屬公司,「 ...